Current Opinion in Neurology

Article	Citations
Medical technologies, telemedicine and artificial intelligence for neurotrauma and neurorehabilitation	67
Management of neuropsychiatric symptoms in dementia	58
Update on management of cerebral venous thrombosis	56
Cortical hyperexcitability in amyotrophic lateral sclerosis: from pathogenesis to diagnosis	55
Chemotherapy and targeted therapies for meningiomas: what is the evidence?	52
The recent surge of functional movement disorders: social distress or greater awareness?	51
The role of the gut microbiome in Alzheimer's disease pathophysiology	42
Hereditary motor neuropathies	40
Historical development and contemporary use of neuromodulation in human spinal cord injury	40
From basic mechanisms to therapeutic perspectives in cluster headache	39
The 2021 WHO classification of central nervous system tumors: what neurologists need to know	36
Gene therapies for CMT neuropathies: from the bench to the clinic	36
Central nervous system adverse events of immune checkpoint inhibitors	35
Primary central nervous system lymphoma: advances in its pathogenesis, molecular markers and targeted therapies	34
T cell dysfunction in glioblastoma: a barrier and an opportunity for the development of successful immunotherapies	28
Microglia in multiple sclerosis – pathogenesis and imaging	28
Editorial: Epilepsy advances in 2023	28
Neurology education in the era of artificial intelligence	28
Connecting tremors – a circuits perspective	27
Editorial introductions	24
Equitable partnerships between scientists and persons living with spinal cord injury will strengthen research scope, quality, and outcomes	24
New chronic inflammatory demyelinating polyneuropathy/Guillain–Barré syndrome guidelines – impact on clinical practise	24
New developments in myotonic dystrophies from a multisystemic perspective	23
Multiple sclerosis in china: the current state of diagnosis and management	23
Development of neural repair therapy for chronic spinal cord trauma: soluble nogo receptor decoy from discovery to clinical trial	22

Updates in neuro-otology	21
Data-driven approaches to neuroimaging biomarkers for neurological and psychiatric disorders: emerging approaches and examples	20
Editorial: Update on movement disorders	20
Editorial: Modern Gestalt approach to neuromuscular disorders: time for a precision Gestalt	20
The pathogenesis of neurologic symptoms of the postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection	20
Clinical impact of molecular profiling in rare brain tumors	19
Tuberculosis of the central nervous system: current concepts in diagnosis and treatment	19
Thymectomy in myasthenia gravis	19
Interest of rare autoantibodies in autoimmune encephalitis and paraneoplastic neurological syndromes: the utility (or futility) of rare antibody discovery	18
Unveiling the neuroimaging-genetic intersections in the human brain	18
The FSHD jigsaw: are we placing the tiles in the right position?	18
COVID-19 related headaches: epidemiology, pathophysiology, impacts, and management	17
Revascularization of arterial occlusions in posterior circulation acute ischemic stroke	17
Levodopa infusion therapies for Parkinson disease	17
Migraine in women: a review	17
Idiopathic intracranial hypertension: expanding our understanding	17
Burning vertex syndrome: a novel unclassified headache- its preliminary observations, and possible mechanisms	17
Threat of resurgence or hope for global eradication of poliovirus?	17
Editorial: Advances in neuro-oncology: stepping in the right direction	17
Update on dermatomyositis	16
fMRI-based spatio-temporal parcellations of the human brain	16
Red flags in multiple sclerosis	16
Gauging and controlling excitability in cortical disorders	16
MRI for the diagnosis of limb girdle muscular dystrophies	16
Obesity-related neuropathy: the new epidemic	15
Electrical stimulation of the peripheral and central vestibular system	15
Parkinson's disease – genetic cause	14
Editorial: The gap between academic advances and therapy development in motor neuron disease	14
Diet and migraine: what is proven?	14
Dysregulation of energy homeostasis in amyotrophic lateral sclerosis	14
Acute stroke care in low and middle-income countries	14
Recent advances in Alzheimer disease genetics	13
Optic neuritis: current challenges in diagnosis and management	13
Neuroinflammation and immunometabolism in neurodegenerative diseases	13
Novel approaches to treatment of leptomeningeal metastases	13
Neuromuscular junction disorders beyond myasthenia gravis	13
Progress in spinal muscular atrophy research	13
Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers	13
Targeting IDH1/IDH2 mutations in gliomas	13
Visually induced dizziness	13
Susceptibility and disease modifier genes in amyotrophic lateral sclerosis: from genetic associations to therapeutic implications	13
New developments in diagnostics and treatment of adult-onset focal dystonia	13
The state of art on the use of patient reported outcomes in migraine	13
Choroid plexuses at the interface of peripheral immunity and tissue repair in multiple sclerosis	13
Towards multimodal cognition-based treatment for cognitive impairment in Parkinson's disease: drugs, exercise, non-invasive brain stimulation and technologies	13
Monitoring multiple sclerosis: digital and fluid phase biomarkers	12
Advanced neuroimaging techniques in epilepsy	12
Abnormal energy metabolism in ALS: a key player?	12
Fluid phase biomarkers in multiple sclerosis	12
Recent insights in striated muscle laminopathies	12

Current opinion: Racial and ethnic health disparities in multiple sclerosis: considering the social determinants of health	12
Update on genetics of amyotrophic lateral sclerosis	12
Coronavirus disease 2019 infection and cerebrovascular diseases: an update on the pathophysiology and management	12
Neurocognitive and psychiatric post-coronavirus disease 2019 conditions: pathogenic insights of brain dysfunction following severe acute respiratory syndrome coronavirus 2 infection	11
Editorial: Making the invisible visible: updates on vestibular neurology	11
Current trend in air pollution exposure and stroke	11
Pharmacotherapy of cerebellar and vestibular disorders	11
Clinical and neuroimaging features of the progressive supranuclear palsy- corticobasal degeneration continuum	11
Imaging cortical lesions in multiple sclerosis	11
Recent advances in portable, low-field magnetic resonance imaging in cerebrovascular disease	11
Editorial: Seizure disorders: 2023 update	11
Long COVID and especially headache syndromes	11
Diagnosing viral encephalitis and emerging concepts	11
Update on modifiable risk factors for Alzheimer's disease and related dementias	11
Life after autoantibody-mediated encephalitis: optimizing follow-up and management in recovering patients	11
Current gaps in acute reperfusion therapies	11
New and emerging pharmacologic treatments for developmental and epileptic encephalopathies	10
Mechanisms of coronavirus infectious disease 2019-related neurologic diseases	10
Immune checkpoint inhibitors induced side effects of the peripheral nervous system	10
Motion sickness: current concepts and management	10
Update on novel multiple sclerosis treatments: from dismal defeat to scintillating success	10
Muscle ultrasound in myopathies	10
Peripheral visual field loss and activities of daily living	10
Nonneurologic causes of binocular diplopia for the neurologist	10
In-vivo diagnosis of cerebral amyloid angiopathy: an updated review	10
Progression in multiple sclerosis – a long-term problem	9
Progress in treatment of gliomas	9
Update on neuroimaging in non-Alzheimer's disease dementia: a focus on the Lewy body disease spectrum	9
Perception and control of a virtual body in immersive virtual reality for rehabilitation	9
Editorial: Innovation and resilience in movement disorders: abundance of creative science despite the covid-19 period	9
Editorial: Cerebrovascular disease	9
Therapeutic thoroughfares for adults living with Pompe disease	8
Interrogating large multiple sclerosis registries and databases: what information can be gained?	8
Assessing the efficacy of duration and intensity prescription for physical activity in mitigating cardiometabolic risk after spinal cord injury	8
Atypical forms of Alzheimer's disease: patients not to forget	8
Ataxin-2 gene: a powerful modulator of neurological disorders	8
Progressive supranuclear palsy: current approach and challenges to diagnosis and treatment	8
Advances in the treatment of neuropathic pain	8
Multiple sclerosis: advances and challenges in diagnosis	8
Ménière's disease: new guidelines, subtypes, imaging, and more	8
Editorial: Advances in brain tumors management: new perspectives and challenges	8
New targets in spontaneous intracerebral hemorrhage	8
Editorial:Framing artificial intelligence to neuromuscular disorders	8
An update on psychogenic nonepileptic seizures	8
Is calcitonin gene-related peptide a reliable biochemical marker of migraine?	8
How to evaluate extent of resection in diffuse gliomas: from standards to new methods	8
Editorial introductions	8
Emerging concepts and therapies for amyotrophic lateral sclerosis	8
Editorial introductions	8
Update on neuroimaging in brain tumours	7
Artificial intelligence in neuroimaging of brain tumors: reality or still promise?	7
Targeting gene fusions in glioma	7
Editorial: Advances in stroke management and upcoming challenges	7
Vestibular and auditory manifestations of migraine	7
Ultra-high dose methylcobalamin and other emerging therapies for amyotrophic lateral sclerosis	7
Neuralgic amyotrophy	7
Cerebellar ataxia, neuropathy, vestibular areflexia syndrome: genetic and clinical insights	7
Lesion network mapping for symptom localization: recent developments and future directions	7
Guillain-Barré syndrome in an era of global infections and 21st century vaccination	7
Combined neuromodulatory approaches in the central nervous system for treatment of spinal cord injury	7
Shifting our attention earlier in the multiple sclerosis disease course	7
The current landscape of epilepsy genetics: where are we, and where are we going?	7
Editorial introductions	7
Editorial introductions	6
Endogenous clues promoting remyelination in multiple sclerosis	6
Socioeconomic disparities in epilepsy care	6
Rescue therapies in epilepsy	6
Headache in infections	6
Editorial: Current opinions in neurology editorial	6
PET-based brain molecular connectivity in neurodegenerative disease	6
The genetics of amyotrophic lateral sclerosis	6
Fragile X-associated tremor/ataxia syndrome: pathophysiology and management	6
New-onset refractory status epilepticus and febrile infection-related epilepsy syndrome	6
Cancer stem cells in gliomas: evolving concepts and therapeutic implications	6
Neuroinflammation in amyotrophic lateral sclerosis: pathogenic insights and therapeutic implications	6
Congenital myasthenic syndromes: increasingly complex	6
Promises and pitfalls of imaging-based biomarkers in motor neuron diseases	6
Persistent aura without infarction	5
The challenge of amyotrophic lateral sclerosis descriptive epidemiology: to estimate low incidence rates across complex phenotypes in different geographic areas	5
Spasticity following brain and spinal cord injury: assessment and treatment	5

Editorial: Update on movement disorders	5
Recent insights into haematology and peripheral nerve disease	5
The role of caffeine in headache disorders	5
Does imaging of the ischemic penumbra have value in acute ischemic stroke with large vessel occlusion?	5
Current drug treatment of myasthenia gravis	5
Current concepts in acute vestibular syndrome and video-oculography	5
Ambulatory seizure detection	5
Leprous neuropathy	5
Update on myelin imaging in neurological syndromes	5
Autoimmune neuromyotonia	5
Editorial introductions	5
Recent advances in epilepsy surgery	5
Recent developments in multiple sclerosis neuropathology	5
The evolving spectrum of complex inherited neuropathies	5
Novel pathophysiological insights in autoimmune myasthenia gravis	5
An update on multiple system atrophy	5
Autoimmune nodopathies, an emerging diagnostic category	5
Progress in the mechanism of neuronal surface P antigen modulating hippocampal function and implications for autoimmune brain disease	5
Medical and neurologic management of brain tumor patients	5
Clinical characteristics of patients with myelin oligodendrocyte glycoprotein antibodies	5
The current clinical perception of myotonic dystrophy type 2	4
Somatic mosaicism in focal epilepsies	4
Editorial introductions	4
Describing and assessing behavioural symptoms in amyotrophic lateral sclerosis with and without frontotemporal dementia: a scoping review	4
Assessment and treatment of neurogenic dysphagia in stroke and Parkinson's disease	4
Amyotrophic lateral sclerosis is a systemic disease: peripheral contributions to inflammation-mediated neurodegeneration	4
Movement disorders in COVID-19 times: impact on care in movement disorders and Parkinson disease	4
Neuromuscular monitoring devices – where to go next?	4
Advances in myopathy research: promising developments and challenges	4
Promoting exogenous repair in multiple sclerosis: myelin regeneration	4
Imaging of sleep disorders in pre-Parkinsonian syndromes	4
Updates for newly diagnosed and recurrent glioblastoma: a review of recent clinical trials	4
Vestibular syncope	4
Systemic vasculitis and headache	4
Defining the presymptomatic phase of frontotemporal dementia	4
Spinal cord pathology revealed by MRI in traumatic spinal cord injury	4
Recent advances, challenges and perspectives in cerebrovascular disease	4
Nerve ultrasound for the diagnosis and follow-up of peripheral neuropathies	4
Pathomechanisms in demyelination and astrocytopathy: autoantibodies to AQP4, MOG, GFAP, GRP78 and beyond	4
Novel trial designs in neuro-oncology	4
How can you manage an indomethacin-responsive headache in someone who cannot take indomethacin?	3
Autoimmune movement disorders with neuronal antibodies – an update	3
Noninvasive methods to monitor intracranial pressure	3
Editorial: Degenerative and cognitive diseases	3
Editorial: Central nervous system inflammatory injury, and now in the time of epidemic	3
Diagnostic criteria for amyotrophic lateral sclerosis	3
Parkinson's disease – current treatment	3
Myoclonus: an update	3
Neuroscience and oncology: state-of-the-art and new perspectives	3
Intravenous thrombolysis for acute ischemic stroke: why not?	3
Recent advances in our understanding of genetic rhabdomyolysis	3
Peripheral white blood cell responses as emerging biomarkers for patient stratification and prognosis in acute spinal cord injury	3
Editorial: Neuromuscular diseases: differential diagnosis and targeted treatment	3
Precision medicine in secondary prevention of ischemic stroke: how may blood-based biomarkers help in clinical routine? An expert opinion	3
Urogenital dysfunction following neurotrauma	3
Advances in functional and structural imaging of the brainstem: implications for disease	3
Epidemiology and genetics of Meniere's disease	3
Re-defining progression in multiple sclerosis	3
Reproducibility and replicability in neuroimaging data analysis	3
Sudden unexpected death in epilepsy	3
Neuropathology and epilepsy surgery	3
Late-onset myopathies	3
The atypical faces of optic neuritis: neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease	3
Vitamins in neuropathy: pathophysiological and therapeutic roles	3
Novel approaches to measuring neurocognitive functions in Alzheimer's disease clinical trials	3
Editorial introductions	3
Traumatic peripheral nerve injuries: diagnosis and management	3
Noninvasive brain stimulation to improve motor outcomes after stroke	3
Traumatic brachial plexus injury: diagnosis and treatment	3